Newsroom

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Value Line Dividend Index UCITS ETF 25.08.2026 FVD. IE00BKVKW020 250,002.00 USD 7,807,816.86 31.231  ...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Emerging Markets AlphaDEX UCITS ETF 25.08.2026 FEM IE00B8X9NX34  300,002.00 USD  15,259,919.08   50.866  ...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Global Capital Strength ESG Leaders UCITS ETF 25.08.2026 FCSG IE00BKPSPT20 650,002.00 USD 30,150,127.91 46.385  ...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust FactorFX UCITS ETF 25.08.2026 FXGB LN IE00BD5HBR05 47,692.00 GBP 1,018,750.93 29.123  ...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust FactorFX UCITS ETF 25.08.2026 FTFX IE00BD5HBQ97 63,402.00 USD 1,794,076.37 28.297  ...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust US Large Cap Core AlphaDEX UCITS ETF 25.08.2026 FEXD.LN IE00BWTNMB87 451,437.00 USD 46,309,763.62 102.583  ...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust US Large Cap Core AlphaDEX UCITS ETF 25.08.2026 FEX.LN IE00B8X9NW27 1,388,395.00 USD 160,807,747.94 115.823  ...

DULUTH, Minn.--(BUSINESS WIRE)--Cirrus (Cirrus Aircraft Ltd.), the global leader in Personal Aviation™, today announced strong interim financial results for the six-month period ending June 30, 2026, attributed to robust demand across the company’s expanded product portfolio, including the SR Series G7+, G3 Vision Jet, and TRAC10 aircraft, resulting in increased operating margin and demonstrating financial strength. “Our H1 2026 performance reflects the growth of the Cirrus brand and product po...

NEW YORK--(BUSINESS WIRE)--Definium Therapeutics, Inc. (Nasdaq: DFTX) ("Definium" or the "Company"), a late-stage clinical biopharmaceutical company developing a new generation of therapeutics intended to address underlying causes of psychiatric and neurological disorders, today announced that members of the Company’s management team will participate in the following investor conferences and events: Stifel Hosted Webinar: Definium Therapeutics Virtual Fireside Chat Presentation Date and Time: T...

SALT LAKE CITY & LVIV, Ukraine--(BUSINESS WIRE)--Palladyne AI and NORDA Dynamics to Integrate SwarmOS™ Collaborative Autonomy Software with NORDA’s Combat-Proven Underdog Autonomy Module...